[ad_1]
Jemal A, Bray F, Middle MM, Ferlay J, Ward E, Forman D. World most cancers statistics. CA: Most cancers J Clin. 2011;61:69–90.
Chen W, Zheng R, Zeng H, Zhang S, He J. Annual report on standing of most cancers in China, 2011. Chin J Most cancers Res. 2015;27:2.
Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an rising platform for most cancers remedy. Nat Nanotechnol. 2007;2:751–60.
Mitragotri S, Burke PA, Langer R. Overcoming the challenges in administering biopharmaceuticals: formulation and supply methods. Nat Rev Drug Discov. 2014;13:655–72.
Danhier F, Feron O, Préat V. To take advantage of the tumor microenvironment: passive and lively tumor concentrating on of nanocarriers for anti-cancer drug supply. J Contr Rel. 2010;148:135–46.
Ekladious I, Colson YL, Grinstaff MW. Polymer–drug conjugate therapeutics: advances, insights and prospects. Nat Rev Drug Discov. 2019;18:273–94.
Zhou M, Huang H, Wang D, Lu H, Chen J, Chai Z, Yao SQ, Hu Y. Gentle-triggered PEGylation/dePEGylation of the nanocarriers for enhanced tumor penetration. Nano Lett. 2019;19:3671–5.
Allen TM, Cullis PR. Liposomal drug supply programs: from idea to medical purposes. Adv Drug Deliv Rev. 2013;65:36–48.
Moradi Kashkooli F, Soltani M, Souri M. Managed anti-cancer drug launch by means of superior nano-drug supply programs: static and dynamic concentrating on methods. J Contr Rel. 2020;327:316–49.
Shreffler JW, Pullan JE, Dailey KM, Mallik S, Brooks AE. Overcoming hurdles in nanoparticle medical translation: the affect of experimental design and floor modification. Int J Mol Sci. 2019;20:6056.
Walsh G. Biopharmaceutical benchmarks 2018. Nat Biotechnol. 2018;36:1136–45.
DeLoach J, Barton C, Culler Okay. Preparation of resealed provider erythrocytes and in vivo survival in canine. Am J Vet Res. 1981;42:667–9.
Pang L, Zhang C, Qin J, Han L, Li R, Hong C, He H, Wang J. A novel technique to realize efficient drug supply: exploit cells as provider mixed with nanoparticles. Drug Deliv. 2017;24:83–91.
Jiang X, Rocker C, Hafner M, Brandholt S, Dorlich RM, Nienhaus GU. Endo-and exocytosis of zwitterionic quantum dot nanoparticles by dwell HeLa cells. ACS Nano. 2010;4:6787–97.
Hu C-MJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic supply platform. Proc Nat Acad Sci. 2011;108:10980–5.
Maeda H. The improved permeability and retention (EPR) impact in tumor vasculature: the important thing position of tumor-selective macromolecular drug concentrating on. Adv Enzyme Regul. 2001;41:189–207.
Sabu C, Rejo C, Kotta S, Pramod Okay. Bioinspired and biomimetic programs for superior drug and gene supply. J Contr Rel. 2018;287:142–55.
Rasheed T, Nabeel F, Raza A, Bilal M, Iqbal H. Biomimetic nanostructures/cues as drug supply programs: a evaluation. Mater At this time Chem. 2019;13:147–57.
Shirley JL, de Jong YP, Terhorst C, Herzog RW. Immune responses to viral gene remedy vectors. Mol Ther. 2020;28:709–22.
von Roemeling C, Jiang W, Chan CK, Weissman IL, Kim BY. Breaking down the boundaries to precision most cancers nanomedicine. Traits Biotechnol. 2017;35:159–71.
Gao M, Liang C, Music X, Chen Q, Jin Q, Wang C, Liu Z. Erythrocyte-membrane-enveloped perfluorocarbon as nanoscale synthetic purple blood cells to alleviate tumor hypoxia and improve most cancers radiotherapy. Adv Mater. 2017;29:1701429.
Cao H, Dan Z, He X, Zhang Z, Yu H, Yin Q, Li Y. Liposomes coated with remoted macrophage membrane can goal lung metastasis of breast most cancers. ACS Nano. 2016;10:7738–48.
Orbach A, Zelig O, Yedgar S, Barshtein G. Biophysical and biochemical markers of purple blood cell fragility. Transf Med Hemother. 2017;44:183–7.
Zhu J-Y, Zheng D-W, Zhang M-Okay, Yu W-Y, Qiu W-X, Hu J-J, Feng J, Zhang X-Z. Preferential most cancers cell self-recognition and tumor self-targeting by coating nanoparticles with homotypic most cancers cell membranes. Nano Lett. 2016;16:5895–901.
Kang T, Zhu Q, Wei D, Feng J, Yao J, Jiang T, Music Q, Wei X, Chen H, Gao X. Nanoparticles coated with neutrophil membranes can successfully deal with most cancers metastasis. ACS Nano. 2017;11:1397–411.
Spicer JD, McDonald B, Cools-Lartigue JJ, Chow SC, Giannias B, Kubes P, Ferri LE. Neutrophils promote liver metastasis through Mac-1-mediated interactions with circulating tumor cells. Can Res. 2012;72:3919–27.
Parodi A, Quattrocchi N, Van De Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, Brown BS, Khaled SZ, Yazdi IK, Enzo MV. Artificial nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like capabilities. Nat Nanotechnol. 2013;8:61–8.
Chugh V, Vijaya Krishna Okay, Pandit A. Cell membrane-coated mimics: a methodological method for fabrication, characterization for therapeutic purposes, and challenges for medical translation. ACS Nano. 2021;15:17080–123.
Engelman DM. Membranes are extra mosaic than fluid. Nature. 2005;438:578–80.
Bucior I, Scheuring S, Engel A, Burger MM. Carbohydrate–carbohydrate interplay offers adhesion power and specificity for mobile recognition. J Cell Biol. 2004;165:529–37.
Simons Okay, Vaz WL. Mannequin programs, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct. 2004;33:269–95.
Casares D, Escribá PV, Rosselló CA. Membrane lipid composition: impact on membrane and organelle construction, operate and compartmentalization and therapeutic avenues. Int J Mol Sci. 2019;20:2167.
Kim J, Koo B-Okay, Knoblich JA. Human organoids: mannequin programs for human biology and medication. Nat Rev Mol Cell Biol. 2020;21:571–84.
Andrews RK, López J, Berndt MC. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol. 1997;29:91–105.
Si J, Shao S, Shen Y, Wang Okay. Macrophages as lively nanocarriers for focused early and adjuvant most cancers chemotherapy. Small. 2016;12:5108–19.
Sökeland G, Schumacher U. The practical position of integrins throughout intra-and extravasation throughout the metastatic cascade. Mol Most cancers. 2019;18:1–19.
Bose RJ, Paulmurugan R, Moon J, Lee S-H, Park H. Cell membrane-coated nanocarriers: the rising focused supply system for most cancers theranostics. Drug Discov At this time. 2018;23:891–9.
Evangelopoulos M, Parodi A, Martinez JO, Yazdi IK, Cevenini A, van de Ven AL, Quattrocchi N, Boada C, Taghipour N, Corbo C. Cell supply determines the immunological impression of biomimetic nanoparticles. Biomaterials. 2016;82:168–77.
Kaneti L, Bronshtein T, Malkah Dayan N, Kovregina I, Letko Khait N, Lupu-Haber Y, Fliman M, Schoen BW, Kaneti G, Machluf M. Nanoghosts as a novel pure nonviral gene supply platform safely concentrating on a number of cancers. Nano Lett. 2016;16:1574–82.
Stephan MT, Moon JJ, Um SH, Bershteyn A, Irvine DJ. Therapeutic cell engineering with surface-conjugated artificial nanoparticles. Nat Med. 2010;16:1035–41.
Van Deun J, Roux Q, Deville S, Van Acker T, Rappu P, Miinalainen I, Heino J, Vanhaecke F, De Geest BG, De Wever O. Feasibility of mechanical extrusion to coat nanoparticles with extracellular vesicle membranes. Cells. 2020;9:1797.
Parrow NL, Violet P-C, Tu H, Nichols J, Pittman CA, Fitzhugh C, Fleming RE, Mohandas N, Tisdale JF, Levine M. Measuring deformability and purple cell heterogeneity in blood by ektacytometry. J Vis Exp JoVE. 2018;2018:56910.
Kuo Y-C, Wu H-C, Hoang D, Bentley WE, D’Souza WD, Raghavan SR. Colloidal properties of nanoerythrosomes derived from bovine purple blood cells. Langmuir. 2016;32:171–9.
Kim DS, Lee MW, Ko YJ, Jang IK, Jeon S, Na B, Chae JJ, Sung KW, Koo HH, Yoo KH. Impact of ex vivo tradition density on CXCR7 expression in human mesenchymal stem cells. Int J Clin Exp Med. 2016;9:10802–10.
Park JS, Suryaprakash S, Lao Y-H, Leong KW. Engineering mesenchymal stem cells for regenerative medication and drug supply. Strategies. 2015;84:3–16.
Muzykantov VR, Murciano JC, Taylor RP, Atochina EN, Herraez A. Regulation of the complement-mediated elimination of purple blood cells modified with biotin and streptavidin. Anal Biochem. 1996;241:109–19.
Wang Y, Zhang Okay, Qin X, Li T, Qiu J, Yin T, Huang J, McGinty S, Pontrelli G, Ren J. Biomimetic nanotherapies: purple blood cell based mostly core–shell structured nanocomplexes for atherosclerosis administration. Adv Sci. 2019;6:1900172.
Hu C-MJ, Fang RH, Wang Okay-C, Luk BT, Thamphiwatana S, Dehaini D, Nguyen P, Angsantikul P, Wen CH, Kroll AV. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015;526:118–21.
Thamphiwatana S, Angsantikul P, Escajadillo T, Zhang Q, Olson J, Luk BT, Zhang S, Fang RH, Gao W, Nizet V. Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis administration. Proc Natl Acad Sci. 2017;114:11488–93.
Deng G, Solar Z, Li S, Peng X, Li W, Zhou L, Ma Y, Gong P, Cai L. Cell-membrane immunotherapy based mostly on pure killer cell membrane coated nanoparticles for the efficient inhibition of major and abscopal tumor development. ACS Nano. 2018;12:12096–108.
An X, Salomao M, Guo X, Gratzer W, Mohandas N. Tropomyosin modulates erythrocyte membrane stability. Blood. 2007;109:1284–8.
Chakraborty S, Doktorova M, Molugu TR, Heberle FA, Scott HL, Dzikovski B, Nagao M, Stingaciu L-R, Standaert RF, Barrera FN. How ldl cholesterol stiffens unsaturated lipid membranes. Proc Natl Acad Sci. 2020;117:21896–905.
Virlan MJR, Miricescu D, Radulescu R, Sabliov CM, Totan A, Calenic B, Greabu M. Natural nanomaterials and their purposes within the therapy of oral illnesses. Molecules. 2016;21:207.
Anselmo AC, Mitragotri S. A evaluation of medical translation of inorganic nanoparticles. AAPS J. 2015;17:1041–54.
Ehlerding EB, Chen F, Cai W. Biodegradable and renal clearable inorganic nanoparticles. Adv Sci. 2016;3:1500223.
Su S, Kang PM. Systemic evaluation of biodegradable nanomaterials in nanomedicine. Nanomaterials. 2020;10:656.
Ye H, Wang Okay, Wang M, Liu R, Music H, Li N, Lu Q, Zhang W, Du Y, Yang W. Bioinspired nanoplatelets for chemo-photothermal remedy of breast most cancers metastasis inhibition. Biomaterials. 2019;206:1–12.
Xu C, Liu W, Hu Y, Li W, Di W. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic remedy. Theranostics. 2020;10:3325.
Zhang Q, Dehaini D, Zhang Y, Zhou J, Chen X, Zhang L, Fang RH, Gao W, Zhang L. Neutrophil membrane-coated nanoparticles inhibit synovial irritation and alleviate joint harm in inflammatory arthritis. Nat Nanotechnol. 2018;13:1182–90.
Tang J, Shen D, Caranasos TG, Wang Z, Vandergriff AC, Allen TA, Hensley MT, Dinh P-U, Cores J, Li T-S. Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. Nat Commun. 2017;8:1–9.
Li L-L, Xu J-H, Qi G-B, Zhao X, Yu F, Wang H. Core–shell supramolecular gelatin nanoparticles for adaptive and “on-demand” antibiotic supply. ACS Nano. 2014;8:4975–83.
Gao C, Lin Z, Jurado-Sánchez B, Lin X, Wu Z, He Q. Stem cell membrane-coated nanogels for extremely environment friendly in vivo tumor focused drug supply. Small. 2016;12:4056–62.
Zhai Y, Ran W, Su J, Lang T, Meng J, Wang G, Zhang P, Li Y. Traceable bioinspired nanoparticle for the therapy of metastatic breast most cancers through NIR-trigged intracellular supply of methylene blue and cisplatin. Adv Mater. 2018;30:1802378.
Rao L, Wang W, Meng Q-F, Tian M, Cai B, Wang Y, Li A, Zan M, Xiao F, Bu L-L. A biomimetic nanodecoy traps Zika virus to forestall viral an infection and fetal microcephaly growth. Nano Lett. 2018;19:2215–22.
Xie J, Shen Q, Huang Okay, Zheng T, Cheng L, Zhang Z, Yu Y, Liao G, Wang X, Li C. Oriented meeting of cell-mimicking nanoparticles through a molecular affinity technique for focused drug supply. ACS Nano. 2019;13:5268–77.
Nie D, Dai Z, Li J, Yang Y, Xi Z, Wang J, Zhang W, Qian Okay, Guo S, Zhu C. Most cancers-cell-membrane-coated nanoparticles with a yolk–shell construction increase most cancers chemotherapy. Nano Lett. 2019;20:936–46.
Castro CI, Briceno JC. Perfluorocarbon-based oxygen carriers: evaluation of merchandise and trials. Artif Organs. 2010;34:622–34.
Zou MZ, Liu WL, Gao F, Bai XF, Chen HS, Zeng X, Zhang XZ. Synthetic pure killer cells for particular tumor inhibition and renegade macrophage re-education. Adv Mater. 2019;31:1904495.
Watermann A, Brieger J. Mesoporous silica nanoparticles as drug supply automobiles in most cancers. Nanomaterials. 2017;7:189.
Jafari S, Derakhshankhah H, Alaei L, Fattahi A, Varnamkhasti BS, Saboury AA. Mesoporous silica nanoparticles for therapeutic/diagnostic purposes. Biomed Pharmacother. 2019;109:1100–11.
Xuan M, Shao J, Zhao J, Li Q, Dai L, Li J. Cowl image: magnetic mesoporous silica nanoparticles cloaked by purple blood cell membranes: purposes in most cancers remedy. Angew Chem Int Ed. 2018;57:5955–5955.
Cai D, Liu L, Han C, Ma X, Qian J, Zhou J, Zhu W. Most cancers cell membrane-coated mesoporous silica loaded with superparamagnetic ferroferric oxide and Paclitaxel for the mixture of Chemo/Magnetocaloric remedy on MDA-MB-231 cells. Sci Rep. 2019;9:1–10.
Hao N, Yang H, Li L, Li L, Tang F. The form impact of mesoporous silica nanoparticles on intracellular reactive oxygen species in A375 cells. New J Chem. 2014;38:4258–66.
Hu C-MJ, Fang RH, Copp J, Luk BT, Zhang L. A biomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotechnol. 2013;8:336–40.
Li J, Ai Y, Wang L, Bu P, Sharkey CC, Wu Q, Wun B, Roy S, Shen X, King MR. Focused drug supply to circulating tumor cells through platelet membrane-functionalized particles. Biomaterials. 2016;76:52–65.
Meng Q-F, Rao L, Zan M, Chen M, Yu G-T, Wei X, Wu Z, Solar Y, Guo S-S, Zhao X-Z. Macrophage membrane-coated iron oxide nanoparticles for enhanced photothermal tumor remedy. Nanotechnology. 2018;29:134004.
Lai P-Y, Huang R-Y, Lin S-Y, Lin Y-H, Chang C-W. Biomimetic stem cell membrane-camouflaged iron oxide nanoparticles for theranostic purposes. RSC Adv. 2015;5:98222–30.
Zhu J, Zhang M, Zheng D, Hong S, Feng J, Zhang X-Z. A common method to render nanomedicine with organic identification derived from cell membranes. Biomacromol. 2018;19:2043–52.
Prepare dinner TR, Zheng Y-R, Stang PJ. Metallic–natural frameworks and self-assembled supramolecular coordination complexes: evaluating and contrasting the design, synthesis, and performance of metallic–natural supplies. Chem Rev. 2013;113:734–77.
Hoop M, Walde CF, Riccò R, Mushtaq F, Terzopoulou A, Chen X-Z, deMello AJ, Doonan CJ, Falcaro P, Nelson BJ. Biocompatibility traits of the metallic natural framework ZIF-8 for therapeutical purposes. Appl Mater At this time. 2018;11:13–21.
Huang J, Shen H, Wu J, Hu X, Zhu Z, Lv X, Liu Y, Wang Y. Backbone Explorer: a deep studying based mostly absolutely automated program for environment friendly and dependable quantifications of the vertebrae and discs on sagittal lumbar backbone MR photographs. Backbone J. 2020;20:590–9.
Carnovale C, Bryant G, Shukla R, Bansal V. Figuring out traits in gold nanoparticle toxicity and uptake: measurement, form, capping ligand, and organic corona. ACS Omega. 2019;4:242–56.
Fang RH, Kroll AV, Gao W, Zhang L. Cell membrane coating nanotechnology. Adv Mater. 2018;30:1706759.
Zhang X, He S, Ding B, Qu C, Zhang Q, Chen H, Solar Y, Fang H, Lengthy Y, Zhang R. Most cancers cell membrane-coated uncommon earth doped nanoparticles for tumor surgical procedure navigation in NIR-II imaging window. Chem Eng J. 2020;385:123959.
Ma W, Zhu D, Li J, Chen X, Xie W, Jiang X, Wu L, Wang G, Xiao Y, Liu Z. Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane offers excessive specificity for hepatocellular carcinoma photothermal remedy therapy. Theranostics. 2020;10:1281.
Mishra P, Jain N. Folate conjugated doxorubicin-loaded membrane vesicles for improved most cancers remedy. Drug Deliv. 2003;10:277–82.
Xuan M, Shao J, Dai L, Li J, He Q. Macrophage cell membrane camouflaged Au nanoshells for in vivo extended circulation life and enhanced most cancers photothermal remedy. ACS Appl Mater Interfaces. 2016;8:9610–8.
Michael M, Vermeren S. A neutrophil-centric view of chemotaxis. Essays Biochem. 2019;63:607–18.
Sekeres J, Zarsky V. 180 years of the cell: from Matthias Jakob Schleiden to the cell biology of the twenty-first century. In: Ideas in cell biology-history and evolution. Berlin: Springer; 2018. p. 7–37.
Goñi FM. The fundamental construction and dynamics of cell membranes: An replace of the Singer-Nicolson mannequin. Biochim Biophys Acta (BBA) Biomembr. 2014;1838:1467–76.
Shi Y, Xie F, Rao P, Qian H, Chen R, Chen H, Li D, Mu D, Zhang L, Lv P. TRAIL-expressing cell membrane nanovesicles as an anti-inflammatory platform for rheumatoid arthritis remedy. J Contr Rel. 2020;320:304–13.
Han Y, Pan H, Li W, Chen Z, Ma A, Yin T, Liang R, Chen F, Ma Y, Jin Y. T cell membrane mimicking nanoparticles with bioorthogonal concentrating on and immune recognition for enhanced photothermal remedy. Adv Sci. 2019;6:1900251.
Lv P, Liu X, Chen X, Liu C, Zhang Y, Chu C, Wang J, Wang X, Chen X, Liu G. Genetically engineered cell membrane nanovesicles for oncolytic adenovirus supply: a flexible platform for most cancers virotherapy. Nano Lett. 2019;19:2993–3001.
Zhang X, Angsantikul P, Ying M, Zhuang J, Zhang Q, Wei X, Jiang Y, Zhang Y, Dehaini D, Chen M. Distant loading of small-molecule therapeutics into cholesterol-enriched cell-membrane-derived vesicles. Angew Chem Int Ed. 2017;56:14075–9.
Peng L-H, Zhang Y-H, Han L-J, Zhang C-Z, Wu J-H, Wang X-R, Gao J-Q, Mao Z-W. Cell membrane capsules for encapsulation of chemotherapeutic and most cancers cell concentrating on in vivo. ACS Appl Mater Interfaces. 2015;7:18628–37.
Zhou H, Fan Z, Lemons PK, Cheng H. A facile method to functionalize cell membrane-coated nanoparticles. Theranostics. 2016;6:1012.
Chai Z, Ran D, Lu L, Zhan C, Ruan H, Hu X, Xie C, Jiang Okay, Li J, Zhou J. Ligand-modified cell membrane permits the focused supply of drug nanocrystals to glioma. ACS Nano. 2019;13:5591–601.
Kaddah S, Khreich N, Kaddah F, Charcosset C, Greige-Gerges H. Ldl cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule. Meals Chem Toxicol. 2018;113:40–8.
Chen Z, Zhao P, Luo Z, Zheng M, Tian H, Gong P, Gao G, Pan H, Liu L, Ma A. Most cancers cell membrane–biomimetic nanoparticles for homologous-targeting dual-modal imaging and photothermal remedy. ACS Nano. 2016;10:10049–57.
Music Y, Huang Z, Liu X, Pang Z, Chen J, Yang H, Zhang N, Cao Z, Liu M, Cao J. Platelet membrane-coated nanoparticle-mediated concentrating on supply of Rapamycin blocks atherosclerotic plaque growth and stabilizes plaque in apolipoprotein E-deficient (ApoE−/−) mice. Nanomed Nanotechnol Biol Med. 2019;15:13–24.
Chen H-Y, Deng J, Wang Y, Wu C-Q, Li X, Dai H-W. Hybrid cell membrane-coated nanoparticles: a multifunctional biomimetic platform for most cancers prognosis and remedy. Acta Biomater. 2020;112:1–13.
Liang X, Ye X, Wang C, Xing C, Miao Q, Xie Z, Chen X, Zhang X, Zhang H, Mei L. Photothermal most cancers immunotherapy by erythrocyte membrane-coated black phosphorus formulation. J Contr Rel. 2019;296:150–61.
Dehaini D, Wei X, Fang RH, Masson S, Angsantikul P, Luk BT, Zhang Y, Ying M, Jiang Y, Kroll AV. Erythrocyte–platelet hybrid membrane coating for enhanced nanoparticle functionalization. Adv Mater. 2017;29:1606209.
St John AE, Newton JC, Martin EJ, Mohammed BM, Contaifer D Jr, Saunders JL, Brophy GM, Spiess BD, Ward KR, Brophy DF. Platelets retain inducible alpha granule secretion by P-selectin expression however exhibit mechanical dysfunction throughout trauma-induced coagulopathy. J Thromb Haemost. 2019;17:771–81.
Solar D, Chen J, Wang Y, Ji H, Peng R, Jin L, Wu W. Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug supply. Theranostics. 2019;9:6885.
Pitchaimani A, Nguyen TDT, Aryal S. Pure killer cell membrane infused biomimetic liposomes for focused tumor remedy. Biomaterials. 2018;160:124–37.
Minasyan H. Phagocytosis and oxycytosis: two arms of human innate immunity. Immunol Res. 2018;66:271–80.
Wang H, Solar Y, Zhou X, Chen C, Jiao L, Li W, Gou S, Li Y, Du J, Chen G, et al. CD47/SIRPα blocking peptide identification and synergistic impact with irradiation for most cancers immunotherapy. J Immunother Most cancers. 2020;8:e000905.
Cao Z, Cheng S, Wang X, Pang Y, Liu J. Camouflaging micro organism by wrapping with cell membranes. Nat Commun. 2019;10:1–10.
Liu J-M, Zhang D-D, Fang G-Z, Wang S. Erythrocyte membrane bioinspired near-infrared persistent luminescence nanocarriers for in vivo long-circulating bioimaging and drug supply. Biomaterials. 2018;165:39–47.
Ren X, Zheng R, Fang X, Wang X, Zhang X, Yang W, Sha X. Purple blood cell membrane camouflaged magnetic nanoclusters for imaging-guided photothermal remedy. Biomaterials. 2016;92:13–24.
Rao L, Meng Q-F, Bu L-L, Cai B, Huang Q, Solar Z-J, Zhang W-F, Li A, Guo S-S, Liu W. Erythrocyte membrane-coated upconversion nanoparticles with minimal protein adsorption for enhanced tumor imaging. ACS Appl Mater Interfaces. 2017;9:2159–68.
Su J, Solar H, Meng Q, Yin Q, Tang S, Zhang P, Chen Y, Zhang Z, Yu H, Li Y. Lengthy circulation red-blood-cell-mimetic nanoparticles with peptide-enhanced tumor penetration for concurrently inhibiting development and lung metastasis of breast most cancers. Adv Func Mater. 2016;26:1243–52.
Fu S, Liang M, Wang Y, Cui L, Gao C, Chu X, Liu Q, Feng Y, Gong W, Yang M. Twin-modified novel biomimetic nanocarriers enhance concentrating on and therapeutic efficacy in glioma. ACS Appl Mater Interfaces. 2018;11:1841–54.
Chai Z, Hu X, Wei X, Zhan C, Lu L, Jiang Okay, Su B, Ruan H, Ran D, Fang RH. A facile method to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug supply. J Contr Rel. 2017;264:102–11.
Jiang Q, Luo Z, Males Y, Yang P, Peng H, Guo R, Tian Y, Pang Z, Yang W. Purple blood cell membrane-camouflaged melanin nanoparticles for enhanced photothermal remedy. Biomaterials. 2017;143:29–45.
Chen W, Zeng Okay, Liu H, Ouyang J, Wang L, Liu Y, Wang H, Deng L, Liu YN. Cell membrane camouflaged hole prussian blue nanoparticles for synergistic photothermal-/chemotherapy of most cancers. Adv Func Mater. 2017;27:1605795.
Li B, Wang F, Gui L, He Q, Yao Y, Chen H. The potential of biomimetic nanoparticles for tumor-targeted drug supply. Nanomedicine. 2018;13:2099–118.
Rosales C. Neutrophil: a cell with many roles in irritation or a number of cell varieties? Entrance Physiol. 2018;9:113.
Morikis VA, Simon SI. Neutrophil mechanosignaling promotes integrin engagement with endothelial cells and motility inside infected vessels. Entrance Immunol. 2018;9:2774.
He Z, Zhang Y, Feng N. Cell membrane-coated nanosized lively focused drug supply programs homing to tumor cells: a evaluation. Mater Sci Eng C. 2020;106:110298.
Xue J, Zhao Z, Zhang L, Xue L, Shen S, Wen Y, Wei Z, Wang L, Kong L, Solar H. Neutrophil-mediated anticancer drug supply for suppression of postoperative malignant glioma recurrence. Nat Nanotechnol. 2017;12:692–700.
Cao X, Hu Y, Luo S, Wang Y, Gong T, Solar X, Fu Y, Zhang Z. Neutrophil-mimicking therapeutic nanoparticles for focused chemotherapy of pancreatic carcinoma. Acta Pharmaceut Sin B. 2019;9:575–89.
Combes F, Meyer E, Sanders NN. Immune cells as tumor drug supply automobiles. J Management Rel. 2020;327:70–87.
Wu M, Le W, Mei T, Wang Y, Chen B, Liu Z, Xue C. Cell membrane camouflaged nanoparticles: a brand new biomimetic platform for most cancers photothermal remedy. Int J Nanomed. 2019;14:4431.
Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT, Sahebkar A. Macrophage plasticity, polarization, and performance in well being and illness. J Cell Physiol. 2018;233:6425–40.
Najafi M, Hashemi Goradel N, Farhood B, Salehi E, Nashtaei MS, Khanlarkhani N, Khezri Z, Majidpoor J, Abouzaripour M, Habibi M. Macrophage polarity in most cancers: a evaluation. J Cell Biochem. 2019;120:2756–65.
Hu C, Lei T, Wang Y, Cao J, Yang X, Qin L, Liu R, Zhou Y, Tong F, Umeshappa CS. Phagocyte-membrane-coated and laser-responsive nanoparticles management major and metastatic most cancers by inducing anti-tumor immunity. Biomaterials. 2020;255:120159.
Homosexual LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Most cancers. 2011;11:123–34.
De Witt SM, Swieringa F, Cavill R, Lamers MM, Van Kruchten R, Mastenbroek T, Baaten C, Coort S, Pugh N, Schulz A. Identification of platelet operate defects by multi-parameter evaluation of thrombus formation. Nat Commun. 2014;5:1–13.
Nelson VS, Jolink A-TC, Amini SN, Zwaginga JJ, Netelenbos T, Semple JW, Porcelijn L, de Haas M, Schipperus MR, Kapur R. Platelets in ITP: victims answerable for their very own destiny? Cells. 2021;10:3235.
Chen S, Lv M, Fang S, Ye W, Gao Y, Xu Y. Poly (I: C) enhanced anti-cervical most cancers immunities induced by dendritic cells-derived exosomes. Int J Biol Macromol. 2018;113:1182–7.
Shang Y, Wang Q, Wu B, Zhao Q, Li J, Huang X, Chen W, Gui R. Platelet-membrane-camouflaged black phosphorus quantum dots improve anticancer impact mediated by apoptosis and autophagy. ACS Appl Mater Interfaces. 2019;11:28254–66.
Wu H, Mu X, Liu L, Wu H, Hu X, Chen L, Liu J, Mu Y, Yuan F, Liu W. Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung most cancers cells through concentrating on LRRC1. Cell Dying Dis. 2020;11:1–14.
Nath S, Mukherjee P. MUC1: a multifaceted oncoprotein with a key position in most cancers development. Traits Mol Med. 2014;20:332–42.
Gordon-Alonso M, Hirsch T, Wildmann C, van der Bruggen P. Galectin-3 captures interferon-gamma within the tumor matrix decreasing chemokine gradient manufacturing and T-cell tumor infiltration. Nat Commun. 2017;8:1–15.
Hanahan D, Weinberg RA. Hallmarks of most cancers: the following technology. Cell. 2011;144:646–74.
Zhang J, Miao Y, Ni W, Xiao H, Zhang J. Most cancers cell membrane coated silica nanoparticles loaded with ICG for tumour particular photothermal remedy of osteosarcoma. Artif Cells Nanomed Biotechnol. 2019;47:2298–305.
Rao L, Yu GT, Meng QF, Bu LL, Tian R, Lin LS, Deng H, Yang W, Zan M, Ding J. Most cancers cell membrane-coated nanoparticles for personalised remedy in patient-derived xenograft fashions. Adv Func Mater. 2019;29:1905671.
Jin J, Krishnamachary B, Barnett JD, Chatterjee S, Chang D, Mironchik Y, Wildes F, Jaffee EM, Nimmagadda S, Bhujwalla ZM. Human most cancers cell membrane-coated biomimetic nanoparticles scale back fibroblast-mediated invasion and metastasis and induce T-cells. ACS Appl Mater Interfaces. 2019;11:7850–61.
Wang C, Wu B, Wu Y, Music X, Zhang S, Liu Z. Camouflaging nanoparticles with mind metastatic tumor cell membranes: a brand new technique to traverse blood–mind barrier for imaging and remedy of mind tumors. Adv Func Mater. 2020;30:1909369.
Kumar P, Van Treuren T, Ranjan AP, Chaudhary P, Vishwanatha JK. In vivo imaging and biodistribution of close to infrared dye loaded brain-metastatic-breast-cancer-cell-membrane coated polymeric nanoparticles. Nanotechnology. 2019;30:265101.
Ribas A. Adaptive immune resistance: how most cancers protects from immune assault. Most cancers Discov. 2015;5:915–9.
Zhang L, Li R, Chen H, Wei J, Qian H, Su S, Shao J, Wang L, Qian X, Liu B. Human cytotoxic T-lymphocyte membrane-camouflaged nanoparticles mixed with low-dose irradiation: a brand new method to reinforce drug concentrating on in gastric most cancers. Int J Nanomed. 2017;12:2129.
Um W, Ko H, You DG, Lim S, Kwak G, Shim MK, Yang S, Lee J, Music Y, Kim Okay, Park JH. Necroptosis-inducible polymeric nanobubbles for enhanced most cancers sonoimmunotherapy. Adv Mater. 2020;32:1907953.
Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity. 2013;39:1–10.
Palmer DH, Midgley RS, Mirza N, Torr EE, Ahmed F, Steele JC, Steven NM, Kerr DJ, Younger LS, Adams DH. A section II examine of adoptive immunotherapy utilizing dendritic cells pulsed with tumor lysate in sufferers with hepatocellular carcinoma. Hepatology. 2009;49:124–32.
Zhang B, Yin Y, Lai RC, Lim SK. Immunotherapeutic potential of extracellular vesicles. Entrance Immunol. 2014;5:518.
Mbongue JC, Nieves HA, Torrez TW, Langridge WH. The position of dendritic cell maturation within the induction of insulin-dependent diabetes mellitus. Entrance Immunol. 2017;8:327.
Gardner A, Ruffell B. Dendritic cells and most cancers immunity. Traits Immunol. 2016;37:855–65.
Cheng S, Xu C, Jin Y, Li Y, Zhong C, Ma J, Yang J, Zhang N, Li Y, Wang C. Synthetic mini dendritic cells increase T cell-based immunotherapy for ovarian most cancers. Adv Sci. 2020;7:1903301.
Zhang C, Zhang J, Shi G, Music H, Shi S, Zhang X, Huang P, Wang Z, Wang W, Wang C. A lightweight responsive nanoparticle-based supply system utilizing pheophorbide a graft polyethylenimine for dendritic cell-based most cancers immunotherapy. Mol Pharm. 2017;14:1760–70.
Fang RH, Jiang Y, Fang JC, Zhang L. Cell membrane-derived nanomaterials for biomedical purposes. Biomaterials. 2017;128:69–83.
Solar Q, Wu J, Jin L, Hong L, Wang F, Mao Z, Wu M. Most cancers cell membrane-coated gold nanorods for photothermal remedy and radiotherapy on oral squamous most cancers. J Mater Chem B. 2020;8:7253–63.
Rao L, Bu LL, Meng QF, Cai B, Deng WW, Li A, Li Okay, Guo SS, Zhang WF, Liu W. Antitumor platelet-mimicking magnetic nanoparticles. Adv Func Mater. 2017;27:1604774.
Wu H-H, Zhou Y, Tabata Y, Gao J-Q. Mesenchymal stem cell-based drug supply technique: from cells to biomimetic. J Contr Rel. 2019;294:102–13.
He H, Guo C, Wang J, Korzun WJ, Wang X-Y, Ghosh S, Yang H. Leutusome: a biomimetic nanoplatform integrating plasma membrane elements of leukocytes and tumor cells for remarkably enhanced strong tumor homing. Nano Lett. 2018;18:6164–74.
Solar M, Duan Y, Ma Y, Zhang Q. Most cancers cell-erythrocyte hybrid membrane coated gold nanocages for close to infrared light-activated photothermal/radio/chemotherapy of breast most cancers. Int J Nanomed. 2020;15:6749.
Gong C, Yu X, You B, Wu Y, Wang R, Han L, Wang Y, Gao S, Yuan Y. Macrophage-cancer hybrid membrane-coated nanoparticles for concentrating on lung metastasis in breast most cancers remedy. J Nanobiotechnol. 2020;18:1–17.
Li M, Xu Z, Zhang L, Cui M, Zhu M, Guo Y, Solar R, Han J, Music E, He Y, Su Y. Focused noninvasive therapy of choroidal neovascularization by hybrid cell-membrane-cloaked biomimetic nanoparticles. ACS Nano. 2021;15:9808–19.
Giampietro C, Taddei A, Corada M, Sarra-Ferraris GM, Alcalay M, Cavallaro U, Orsenigo F, Lampugnani MG, Dejana E. Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells. Blood J Am Soc Hematol. 2012;119:2159–70.
Pisano S, Pierini I, Gu J, Gazze A, Francis LW, Gonzalez D, Conlan RS, Corradetti B. Immune (Cell) derived exosome mimetics (IDEM) as a therapy for ovarian most cancers. Entrance Cell Dev Biol. 2020;8:553576.
Susa F, Limongi T, Dumontel B, Vighetto V, Cauda V. Engineered extracellular vesicles as a dependable instrument in most cancers nanomedicine. Cancers. 1979;2019:11.
Jin Okay, Luo Z, Zhang B, Pang Z. Biomimetic nanoparticles for irritation concentrating on. Acta Pharmaceut Sin B. 2018;8:23–33.
Xia Y, Rao L, Yao H, Wang Z, Ning P, Chen X. Engineering macrophages for most cancers immunotherapy and drug supply. Adv Mater. 2020;32:2002054.
[ad_2]
